Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Comment
  • Published:

Hepatitis C testing, treatment and prevention in low- and middle-income country prisons

Nature Reviews Gastroenterology & Hepatology volume 19, pages 484–485 (2022)Cite this article

Subjects

Hepatitis C virus (HCV) infection is common among people who are incarcerated in low- and middle-income countries. Prison policy changes towards HCV testing and treatment are pivotal for social justice and can be a crucial step for achieving HCV global elimination targets.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to the full article PDF.

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. Salari, N. et al. Global prevalence of hepatitis C in prisoners: a comprehensive systematic review and meta-analysis. Arch. Virol. https://doi.org/10.1007/s00705-022-05382-1 (2022).

    Article  PubMed  Google Scholar 

  2. Stone, J. et al. Incarceration history and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis. Lancet Infect. Dis. 18, 1397–1409 (2018).

    Article  Google Scholar 

  3. World Health Organization. Access to hepatitis C testing and treatment for people who inject drugs and people in prisons - a global perspective: policy brief (WHO, 2019).

  4. Supanan, R. et al. Brief Report: HCV universal test-and-treat with direct acting antivirals for prisoners with or without HIV: a prison health care workers-led model for HCV microelimination in Thailand. J. Acquir. Immune Defic. Syndr. 88, 465–469 (2021).

    Article  Google Scholar 

  5. World Health Organization. Recommendations and guidance on hepatitis C virus self-testing (WHO, 2021).

  6. Spaulding, A. C. et al. Funding hepatitis C treatment in correctional facilities by using a nominal pricing mechanism. J. Correct. Health Care 25, 15–24 (2019).

    Article  Google Scholar 

  7. Assoumou, S. A. et al. Cost-effectiveness and budgetary impact of hepatitis C virus testing, treatment, and linkage to care in US prisons. Clin. Infect. Dis. 70, 1388–1396 (2020).

    Article  Google Scholar 

  8. Mendizabal, M. et al. Pilot study using the ECHO model to enhance linkage to care for patients with hepatitis C in the custodial setting. J. Viral. Hepat. 27, 1430–1436 (2020).

    Article  Google Scholar 

  9. Treacy, S., Martin, S., Samarutilake, N. & Van Bortel, T. Patient and public involvement (PPI) in prisons: the involvement of people living in prison in the research process – a systematic scoping review. Health Justice 9, 30 (2021).

    Article  Google Scholar 

  10. Topp, S. M. et al. The health system accountability impact of prison health committees in Zambia. Int. J. Equity Health 17, 74 (2018).

    Article  Google Scholar 

Download references

Acknowledgements

The authors thank SESH (social entrepreneurship to spur health) for administrative support.

Author information

Authors and Affiliations

  1. Institute for Global Health and Infectious Diseases, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA

    Joseph D. Tucker

  2. Clinical Research Department, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK

    Joseph D. Tucker

  3. Section of Infectious Diseases, Department of Internal Medicine, Yale University, New Haven, CT, USA

    Ahsan Ahmad & Adeeba Kamarulzaman

  4. Infectious Diseases Unit, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia

    Ahsan Ahmad & Adeeba Kamarulzaman

  5. Viral Diseases Research Team, Armauer Hansen Research Institute, Addis Ababa, Ethiopia

    Andargachew Mulu

  6. Tuberculosis Programs Division, Center for Infectious Diseases Research in Zambia, Lusaka, Zambia

    Monde Muyoyeta

  7. Internal Medicine Service, Malaysian Ministry of Health, Kuala Lumpur, Malaysia

    Muhammad Radzi Abu Hassan

  8. Clinical Research Department, Hospital Sultanah Bahiyah, Alor Setar, Kedah, Malaysia

    Muhammad Radzi Abu Hassan

Authors
  1. Joseph D. Tucker
    View author publications

    Search author on:PubMed Google Scholar

  2. Ahsan Ahmad
    View author publications

    Search author on:PubMed Google Scholar

  3. Andargachew Mulu
    View author publications

    Search author on:PubMed Google Scholar

  4. Monde Muyoyeta
    View author publications

    Search author on:PubMed Google Scholar

  5. Muhammad Radzi Abu Hassan
    View author publications

    Search author on:PubMed Google Scholar

  6. Adeeba Kamarulzaman
    View author publications

    Search author on:PubMed Google Scholar

Corresponding author

Correspondence to Joseph D. Tucker.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tucker, J.D., Ahmad, A., Mulu, A. et al. Hepatitis C testing, treatment and prevention in low- and middle-income country prisons. Nat Rev Gastroenterol Hepatol 19, 484–485 (2022). https://doi.org/10.1038/s41575-022-00645-3

Download citation

  • Published:

  • Version of record:

  • Issue date:

  • DOI: https://doi.org/10.1038/s41575-022-00645-3

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing